Voriconazole Pregnancy and Breastfeeding Warnings
Voriconazole is also known as: Vfend
Voriconazole Pregnancy Warnings
Voriconazole has been assigned to pregnancy category D by the FDA. Animal studies have revealed evidence of teratogenicity and embryolethality at doses ranging from 0.3 to 6 times (when adjusted for body surface area) the recommended maintenance dose. There are no controlled data in human pregnancy. Voriconazole can cause fetal harm when administered to a pregnant patient. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. Women of childbearing potential should use effective contraception during treatment.
Voriconazole caused cleft palates, hydronephrosis and hydroureter in the offspring of rats when administered to pregnant females at a dose of 10 mg/kg (0.3 times the recommended maintenance dose on a mg/m2 basis). It was embryotoxic when administered to rabbits at a dose of 100 mg/kg (6 times the recommended maintenance dose on a mg/m2 basis). Other teratogenic effects in rats included reduced ossification of sacral and caudal vertebrae, skull, pubic and hyoid bone. Dilation of the ureter/renal pelvis was also observed. In the pregnant rats, decreased plasma estradiol levels were observed. The effects seen in rabbits included an increased embryolethality, reduced fetal weight and increased incidences of skeletal variations, cervical ribs and extra sternebral ossification sites.
Voriconazole Breastfeeding Warnings
There are no data on the excretion of voriconazole into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
- voriconazole Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.